Kiniksa Pharmaceuticals International, plc
KNSA • NASDAQ
Kiniksa Pharmaceuticals International, plc is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanj K. Patel, with a market cap of $3.6B.
Market Cap$3.6B
Employees297.0
CEOSanj K. Patel
CountryBermuda
Healthcare
Biotechnology
Next EarningsApr 28, 2026 · In 2 weeksQ1 2026
Financials
Kiniksa Pharmaceuticals International, plc FAQ
Common questions about Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc is scheduled to report earnings for Q1 2026 on April 28, 2026. Analysts estimate revenue of $205.7M.
Kiniksa Pharmaceuticals International, plc has approximately 297 employees.